Tag: Research

LSU’s Research Endeavors Soar to New Heights

In an impressive leap forward, Louisiana State University (LSU) announced last year that their research activity for 2022 had surpassed the significant milestone of $400 million, reaching a commendable $428 million across its eight campuses. This year, LSU has outdone itself once again, revealing a combined research activity of $488 million for 2023—an almost $500 million achievement, as per this news release from LSU. This noteworthy increase marks a 14 percent rise, surpassing the university’s goal of a 10 percent annual growth in its collaborative research endeavors.

LSU President William F. Tate IV expressed immense pride in the faculty and their collaborative efforts that culminated in these outstanding research endeavors. He emphasized that the university’s scholars and staff are spearheading discovery and innovation, not only for Louisiana but for global benefit. “At LSU, we build teams that win in research,” he stated, highlighting the university’s commitment to excellence.

The measure of university research endeavors is best captured through expenditures. These expenditures, largely funded by grants and contracts, provide a clear indicator of sustained effort and operational capacity in research. Unlike large project awards, which can appear as isolated successes upon announcement, expenditures reflect ongoing investment and their broader economic impact. For LSU, the 2023 research activity translated into a substantial $1.3 billion economic boost for Louisiana.

Robert Twilley, LSU’s Vice President of Research and Economic Development, noted that success in research hinges on talented faculty and top-tier facilities that attract federal funding. This funding enables LSU to recruit exceptional students and make groundbreaking discoveries that enhance the lives of Louisiana’s residents. Twilley also pointed out that significant recent grants, such as the $160 million from the National Science Foundation aimed at securing Louisiana’s energy future, will begin reflecting in expenditures around 2025, indicating a promising upward trend in LSU’s national rankings and competitiveness.

American research universities are ranked based on their ability to secure federal funding. The National Science Foundation (NSF) is anticipated to confirm LSU’s 2023 figures and provide an updated national ranking by November 2024. Historically, LSU’s ranking has been based solely on its Baton Rouge campuses—the flagship campus, the AgCenter, and the Pennington Biomedical Research Center—which reported a 12 percent increase in research activity from $344 million in 2022 to $384 million in 2023. LSU is now working on combining its statewide research numbers to present its full research capacity in the NSF’s annual Higher Education Research and Development (HERD) survey.

The rapid growth in LSU’s research activities is a testament to the university’s strategic Scholarship First Agenda, which aims to propel research investments to advance scientific solutions in agriculture, biomedicine, coastal resilience, defense, and energy. Some of the federally funded projects driving LSU’s historic 2023 research achievements include:

LSU’s College of Agriculture and AgCenter are spearheading a $10 million initiative funded by the National Institute of Food & Agriculture to develop more sustainable rice varieties. This project aims to enhance rice production while utilizing less land, water, and energy. Researchers across various LSU locations, including Crowley and Winnsboro, are leading this effort to boost global food sustainability.

LSU researchers are addressing the decline of Roseau cane, vital for coastal stability and erosion prevention along the Gulf Coast. A $1.6 million investment from the U.S. Department of Agriculture’s Animal & Plant Health Inspection Service in 2022 supports this interdisciplinary research, aiming for restoration and protection of these critical coastal ecosystems.

LSU’s fiscal year 2023, spanning from July 1, 2022, to June 30, 2023, marked a period of remarkable achievements and growth in research activity. The university’s strategic initiatives and collaborative efforts continue to position LSU as a leader in research and innovation, with significant economic and societal impacts.

For more education-related information, click here.

UL Lafayette’s New Biosafety Lab: Pioneering Research

The University of Louisiana at Lafayette (UL Lafayette) has embarked on a transformative journey by expanding its New Iberia Research Center (NIRC). This expansion is set to revolutionize the region’s capabilities in scientific research and economic development, according to this news release from UL Lafayette. The highlight of this ambitious project is the construction of a Level 3 biosafety lab, a facility designed to enhance the scope and depth of research conducted on-site.

The recent groundbreaking ceremony for the Level 3 biosafety lab signifies a monumental step forward. This lab is poised to become a cornerstone in Louisiana’s emerging economic sector. The significance of this development cannot be overstated, as it promises to elevate the state’s status in the realm of advanced biomedical research.

Alongside the biosafety lab, the construction of the Iberia BioInnovation Accelerator at Progress Point Business Parkis underway. Together, these facilities will form the Bieaux Tech Technology Hub, a cutting-edge research and development nexus in Iberia Parish. This hub will be instrumental in fostering innovation and collaboration, propelling the region to the forefront of biopharmaceutical advancements.

Dr. Joseph Savoie, President of UL Lafayette, emphasized the critical role the new biosafety lab will play in addressing healthcare challenges and improving health outcomes. During the groundbreaking event, he articulated the vision of a future where research, testing, manufacturing, and market release of new drugs occur within a compact, efficient 5-mile radius. This integrated approach not only streamlines the drug development process but also holds the potential to significantly benefit global healthcare and the local economy.

The combined capabilities of NIRC, the biopharmaceutical manufacturing facility, and the BioInnovation Acceleratorpaint a promising picture of the future. This comprehensive ecosystem is designed to foster rapid advancements in drug development, positioning the region as a hub of innovation and economic growth.

The development of these projects is supported by a substantial investment of nearly $50 million in state capital outlay funds. Legislative leaders in Acadiana have been instrumental in securing these funds, demonstrating a strong commitment to the region’s advancement. Approximately $25 million is allocated for the expansion of NIRC, which holds the distinction of being the largest non-human primate center in the United States. An additional $22 million is dedicated to the establishment of the BioInnovation Accelerator’s drug manufacturing facility at Progress Point.

Dr. Ramesh Kolluru, Vice President for Research, Innovation, and Economic Development at UL Lafayette, described the projects as “transformational.” He highlighted the collaborative efforts that have made these developments possible, underscoring the shared vision for the greater good of the community and beyond.

The preliminary economic impacts of these projects are substantial. The creation of nearly 550 new jobs and an annual tax revenue of $10.6 million for Iberia Parish are among the immediate benefits. The total economic output is projected to reach an impressive $144.3 million. These figures reflect the significant boost to the local economy and the positive ripple effects that such large-scale projects can generate.

Moreover, the Acadiana Planning Commission (APC) and the University are actively working on leveraging NIRC’s enhanced capabilities. With a $500,000 federal grant secured by APC, there are plans to develop a biopharmaceutical manufacturing cluster in Iberia Parish. This initiative aims to attract drug manufacturers to the region, enabling them to utilize the state-of-the-art facilities for drug development and testing.

At the groundbreaking event, Taylor Barras, Commissioner of Administration for Louisiana, commended the collaborative efforts of higher education, state government, and local government. He noted that economic development was a top priority for Governor Jeff Landry and praised the teamwork that has driven these projects forward.

The completion of both the Level 3 biosafety lab and the BioInnovation Accelerator is anticipated within the next two years. As these projects come to fruition, they are expected to usher in a new era of innovation, economic prosperity, and improved healthcare outcomes for the region and beyond.

For more education-related information, click here.

UL Lafayette Achieves Elite Tier of Carnegie Classification for Research

The University of Louisiana at Lafayette is now ranked at the highest level of research institutions in the United States, according to a news release from the university. According to the latest update from the Carnegie Classification of Institutions of Higher Education, UL Lafayette achieved Carnegie’s elite R1 designation, placing the school among the highest tier of public and private research institutions, something that only 3% of the United States’s colleges and universities have achieved.

Achieving the status of being a recognized R-1 institution indicates that a higher learning institution has met high standards in research spending, staff levels, and the number of doctorates awarded annually. Being classified as a Research-1 or R-1 institution not only elevated UL Lafayette and its profile, allowing the school to draw more prestigious and learned faculty, but it also is likely to attract more research dollars and private support.

Having an R1 status is synonymous with achieving remarkable levels of academic excellence, substantial research, transformative innovation, and lasting global impact. Other R-1 institutions in the country are Duke, Emory, Carnegie-Mellon, Georgia Institute of Technology, Harvard, and Rice. In addition to UL Lafayette, Louisiana’s only other R-1 institutions are Louisiana State University and Tulane University.

UL Lafayette President Dr. Joseph Savoie said of the milestone, “the University of Louisiana at Lafayette is excited to have achieved R-1 status and to take our place among the top tier of the nation’s research universities. The designation by the Carnegie Classification of Institutions of Higher Learning is a recognition of the strength of our research program. It is a tribute to the faculty, staff and student researchers whose work has pushed the bounds of scholarship and innovation and drawn significant national and international attention to the University and to the region it is proud to serve.”

Carnegie classifications for Doctoral Universities are given to institutions that award at least 20 research/scholarship doctoral degrees during a year and institutions with fewer than 20 research/scholarship doctoral degrees awarded at least 30 professional practice doctoral degrees in at least 2 programs. Both of these categories of institutions must also have had at least $5 million in total research expenditures according to the National Science Foundation Higher Research & Development Survey. The three levels of Carnegie’s designations for such higher learning institutions are:

  • R1: Doctoral Universities- Very high research activity
  • R2: Doctoral Universities- High research activity
  • D/PU: Doctoral/Professional Universities.

At the tail end of 2021, The Chronicle of Higher Education reported that UL Lafayette was among nine other universities that were promoted to Carnegie’s highest classification of “Doctoral/Very High Research” institutions.  The other universities elevated were:

University of Louisiana System President and CEO Jim Henderson said, “this tremendous accomplishment is the realization of a purposeful research vision centered on improving life in Louisiana and around the globe. I want to congratulate President Savoie, Vice President (Ramesh) Kolluru, and the faculty of UL Lafayette for achieving this designation, an achievement of nearly unrivaled importance for our state and her people.”

Since 1970, the Carnegie Classification has stood as the leading framework for “describing institutional diversity in U.S. higher education for the past four and a half decades,” as per the Carnegie Classification of Institutions of Higher Education. For four and a half decades, this classification has served as a benchmark of excellence when it comes to institutions of higher learning, and for UL Lafayette to not only join the R1 Doctoral University ranks of LSU and Tulane but also ivy league schools, it’s a momentous achievement that only makes the post-secondary educational experience in Louisiana that much stronger.

For more education-related information, click here.

Tulane Research: Fighting the Epidemic

Researchers stemming from various areas of study at Tulane University have been crucial factors in the effort to combat contagious disease epidemics around the world. In the exhibit OutBreak: Epidemics in a Connected World, the extensive efforts of the researchers are chronicled. The exhibit, which is co-sponsored by The Smithsonian National Museum of Natural History, is a part of the Smithsonian’s Outbreak project. As the world’s population increases, interactions between humans, animals, and the environment also increases. Hence, this project aims to increase awareness of human, animal, and environmental components that influence contagious disease epidemics. By gathering global partners to work together, the project aspires to stop outbreaks before they even have the chance to occur. The diseases featured in the Outbreak exhibit include cancer, the common cold, Ebola, HIV, leprosy, and Yellow Fever.

In response to the exhibit, vice president of research, Dr. Laura Levy, says, “From its inception, Tulane has been a leader in the fight against infectious diseases. This is an opportunity to share that story with those who may not be familiar with some of the groundbreaking advances that have happened right here in New Orleans at Tulane.”

The exhibit begins with the history of Tulane University, which was founded in 1834 by seven doctors who yearned to fight the spread of Yellow Fever, malaria, and smallpox. From that premise, the university went on to be a center of innovative research for issues of global contagion. Some of the most prevalent breakthroughs affiliated with the university are the discovery of the linkage of cigarette smoking to lung cancer, the development of tests to guarantee the safety of polio and measles vaccines, and the isolation of the common cold virus by Dr. William J. Mogabgab in 1955. The development of the first single-lens binocular microscope is also linked to Tulane. With the development of this microscope came the first documented study of cholera.

Some of the more modern-day research at the university includes the study of gene therapy in primates to assist children with genetic disorders, the development of an improved diagnostic test for Lyme disease, and continued research of diseases such as HIV and Ebola. Consequently, when the Ebola epidemic emerged in Sierra Leone, Tulane researches were of the first to respond.

The exhibit’s research was led primarily by Sally Baker, a MD/PhD graduate student in the School of Medicine. As a young ambassador for the American Society of Microbiology, she collaborated with the Office of Communications and Marketing at Tulane to put the exhibit together. When asked about the basis of the exhibit, Baker said, “Today, we continue to struggle with epidemics, such as the current measles outbreak. I thought it was important to highlight some of the work that Tulane has done in the field of infectious disease, particularly working to develop better vaccines and prevent outbreaks. We wanted to bring that knowledge to the public in an exhibit.”

Tulane University’s Outbreak exhibit is described as a regional version of a larger-scale endeavor. In 2018 – the 100thanniversary of 1918’s Great Influenza pandemic – The Smithsonian unveiled a national Outbreak exhibit in Washington, D.C. This national exhibit spans at 4,250 square feet and will remain open until February of 2021. The exhibit is fueled by the premise of the connectivity of virus and seeks to maintain that in order to suppress outbreaks, people from several different fields must band together to carry out “coordinated detective work.”

Tulane’sOutBreak: Epidemics in a Connected Worldopened on May 1 and will run until July 31, 2019. The exhibit is free-of-charge and is located in the Diboll Gallery of the Tidewater Building, 1440 Canal Street.

For more education related information, click here.